Other languages Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Market Closed - Nasdaq Stockholm Other stock markets 08:59:55 03/05/2024 pm IST			5-day change	1st Jan Change
0.0328 ^SEK	-10.87%		-9.89%	-65.47%

18/04	Prostatype Genomics Announces Very Strong Interim Results from Long-Term Follow-Up Study with Prostatype in Uppsala	CI
17/04	Prostatype Genomics Updates on Significant Progress in the US Study with Prostatype®	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prostatype Genomics Announces Very Strong Interim Results from Long-Term Follow-Up Study with Prostatype in Uppsala	18/04
Prostatype Genomics Updates on Significant Progress in the US Study with Prostatype®	17/04
Prostatype Genomics Announces Strong Positive Final Results from Multicentre Study with Prostatype®? in Spain	16/04
Prostatype Genomics AB Announces Strong Positive Final Results from Multicentre Study with Prostatype in Spain	16/04
Prostatype Genomics Enters into Collaboration with Professor E. David Crawford University of California San Diego, in Preparation for the Commercial Launch of Prostatype in the United States	02/04
Prostatype Genomics AB Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Prostatype Genomics AB Announces Long Term Follow Up Study At Akademiska University Hospital, Uppsala, to Be Presented At EAU-Meeting, May 2024: Indicates New Area of Use for Prostatype®	22/12
Prostatype Genomics to Raise SEK48 Million via Rights Issue; Shares Slump	07/11
Prostatype Genomics AB Announces Henrik Nilsson to Leave the Board of Directors Prematurely	07/11
Prostatype Genomics Secures Prostate Cancer Test Order From Swiss Institution; Shares Surge	01/11
Prostatype Genomics AB Receives the First Order of Prostatype in Switzerland from One of the Country's Major University Hospitals	01/11
Prostatype Genomics Appoints New CFO	31/23/31
Prostatype Genomics AB Announces Updated Strategy and Implementation of Efficiency Programs in Prostatype Genomics	30/23/30
Prostatype Genomics’ Prostate Cancer Test Shows Efficiency in Initial Results of Multicenter Study	25/23/25
Prostatype Genomics Announces New Multi-Centre Study in Spain Shows Very Strong Interim Results for Prostatype(R)	25/23/25
Prostatype Genomics CFO to Depart in December	05/23/05
Prostatype Genomics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17
Prostatype Genomics AB Provides Revenue Guidance for the Third Quarter of 2023	17/23/17
Prostatype Genomics AB Appoints Gerald Andriole as Chief Medical Officer	20/23/20
Prostatype Genomics AB Announces Executive Changes	01/23/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Other languages

Filters